Phase-0 Microdosing Network Board of Directors


Kirsten Anderson

Kirsten Anderson is currently Senior Vice President of Clinical Development at Presage Biosciences, responsible for strategic oversight of all aspects of clinical trials, including trial design, regulatory, operations, pharmacovigilance, and biometrics. Kirsten has nearly 30 years of experience in the pharmaceutical industry, with expertise in oncology drug development. She has held clinical trial management positions at OncoGenex, Sonus Pharmaceuticals, Xcyte Therapies, and Immunex. Kirsten earned a Master’s in Biotech Enterprise from Johns Hopkins and has a bachelor’s degree in biology from the University of Vermont.